--- title: "12 Health Care Stocks Moving In Tuesday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/281914807.md" description: "In Tuesday's intraday session, several health care stocks experienced significant movements. Gainers included Lunai Bioworks (up 47.2% to $0.41), SILO Pharma (up 46.0% to $0.52), and Advanced Biomed (up 43.09% to $6.33). Notable losers were Profusa (down 33.0% to $1.24), Grace Therapeutics (down 17.94% to $3.34), and Aditxt (down 16.13% to $0.5)." datetime: "2026-04-07T17:05:57.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281914807.md) - [en](https://longbridge.com/en/news/281914807.md) - [zh-HK](https://longbridge.com/zh-HK/news/281914807.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Tuesday's Intraday Session ### Gainers - **Lunai Bioworks** (NASDAQ:LNAI) stock moved upwards by 47.2% to $0.41 during Tuesday's regular session. The market value of their outstanding shares is at $6.8 million. - **SILO Pharma** (NASDAQ:SILO) shares rose 46.0% to $0.52. The market value of their outstanding shares is at $4.7 million. - **Advanced Biomed** (NASDAQ:ADVB) stock increased by 43.09% to $6.33. The market value of their outstanding shares is at $6.0 million. - **Estrella Immunopharma** (NASDAQ:ESLA) stock increased by 35.25% to $1.84. The market value of their outstanding shares is at $58.0 million. - **Quince Therapeutics** (NASDAQ:QNCX) shares rose 29.48% to $0.11. The company's market cap stands at $4.8 million. - **Axe Compute** (NASDAQ:AGPU) shares increased by 26.58% to $5.38. The market value of their outstanding shares is at $14.4 million. ### Losers - **Profusa** (NASDAQ:PFSA) stock fell 33.0% to $1.24 during Tuesday's regular session. The market value of their outstanding shares is at $2.5 million. - **Grace Therapeutics** (NASDAQ:GRCE) shares declined by 17.94% to $3.34. The market value of their outstanding shares is at $62.9 million. - **Aditxt** (NASDAQ:ADTX) stock decreased by 16.13% to $0.5. - **Pulse Biosciences** (NASDAQ:PLSE) shares declined by 15.2% to $19.45. The market value of their outstanding shares is at $1.5 billion. - **Cyclerion Therapeutics** (NASDAQ:CYCN) shares fell 15.19% to $3.52. The market value of their outstanding shares is at $15.7 million. - **Neuronetics** (NASDAQ:STIM) stock decreased by 14.49% to $1.5. The market value of their outstanding shares is at $121.9 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md) - [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md) - [PFSA.US](https://longbridge.com/en/quote/PFSA.US.md) - [ADVB.US](https://longbridge.com/en/quote/ADVB.US.md) - [GRCE.US](https://longbridge.com/en/quote/GRCE.US.md) - [SILO.US](https://longbridge.com/en/quote/SILO.US.md) - [RENB.US](https://longbridge.com/en/quote/RENB.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) ## Related News & Research - [Silo Pharma says Canada issues notice of allowance for SPC-15 PTSD patent application](https://longbridge.com/en/news/296265804.md) - [Silo Pharma issues 165,000 unregistered shares in asset purchase deal](https://longbridge.com/en/news/296402385.md) - [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md) - [Grace Therapeutics posts investor deck on IV nimodipine candidate GTx-104 for aneurysmal subarachnoid hemorrhage](https://longbridge.com/en/news/295795632.md) - [LIVE MARKETS-BofA clients flock to tech stocks](https://longbridge.com/en/news/296383193.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**